Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 2/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | MAT2A | P31153 | 1/20 | 0.34 |
| ▸ | F11 | P03951 | 2/20 | 0.33 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526076 | 0.93 | PGK1 (0.46) | PGK1MAPTKDM4ENSD2ALDH1A1 | |
| SCHEMBL22109509 | 0.80 | KDM1A (0.43) | MAPTKDM4ENSD2ALDH1A1MAOA | |
| SCHEMBL24163775 | 0.78 | KDM4E (0.42) | MAPTKDM4ENSD2ALDH1A1POLB | |
| SCHEMBL24163221 | 0.77 | MAPT (0.41) | PGK1MAPTKDM4ENSD2ALDH1A1 | |
| SCHEMBL29313505 | 0.75 | KDM4E (0.46) | MAPTKDM4ENSD2ALDH1A1POLB | |
| SCHEMBL29318283 | 0.74 | KDM4E (0.39) | MAPTKDM4ENSD2ALDH1A1KDM1A | |
| SCHEMBL21246780 | 0.74 | KDM4E (0.53) | PGK1MAPTKDM4ENSD2ALDH1A1 | |
| SCHEMBL29109563 | 0.74 | KDM4E (0.44) | PGK1MAPTKDM4ENSD2ALDH1A1 | |
| SCHEMBL33527400 | 0.73 | ALDH1A1 (0.41) | PGK1MAPTKDM4ENSD2ALDH1A1 | |
| SCHEMBL24930081 | 0.71 | KDM4E (0.42) | MAPTKDM4ENSD2ALDH1A1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | PGK1 4072/4885MAPT 4878/4885KDM4E 2674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.